TransMedics Group (TMDX) Announces Scheduling of OCS Heart FDA Advisory Committee Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. NVDA
7. PRIM
8. META
9. SPY
10. DPZ

Go back to TransMedics Group (TMDX) Announces Scheduling of OCS Heart FDA Advisory Committee Meeting

TransMedics Group (TMDX) Tops Q4 EPS by 2c, Revenues Beat

March 2, 2021 4:24 PM EST

TransMedics Group (NASDAQ: TMDX) reported Q4 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $6.04 million.

Recent Highlights

Net revenue of $7.6 million in the fourth quarter of 2020, representing 26% growth... More